Matinas Biopharma (MTNB) Stock Chart & Stock Price History $1.79 -0.04 (-2.19%) As of 01:53 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Matinas Biopharma Stock Price Performance The Matinas Biopharma (MTNB) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 248.04%. In the past month, the stock has decreased 24.79%, reflecting recent market activity. As of the latest close, Matinas Biopharma traded at $1.83 with a market cap of $9.31 million and volume of 48,214 shares. Five years ago, the stock traded at $0.77, representing a 129.39% increase over that period. At the time, it had a market cap of $153.89 million and a volume of 3.40 million shares. Receive MTNB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Matinas Biopharma and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+9.57%1 Month Performance-24.79%3 Month Performance+111.31%Year-To-Date Performance+248.04%5 Year Performance+129.39% MTNB Stock Chart for Monday, September, 15, 2025 MTNB Chart by TradingView Matinas Biopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/12/2025$1.80$1.83+1.67%$1.88$1.7648,214 shs$9.31 million09/11/2025$1.62$1.80+11.11%$1.80$1.6294,464 shs$9.16 million09/10/2025$1.64$1.62-1.22%$1.70$1.5927,315 shs$8.24 million09/09/2025$1.67$1.64-1.80%$1.70$1.6039,199 shs$8.34 million09/08/2025$1.72$1.67-2.91%$1.75$1.6345,899 shs$8.50 million09/05/2025$1.69$1.72+1.78%$1.77$1.6549,236 shs$8.75 million09/04/2025$1.82$1.69-7.14%$1.78$1.6477,335 shs$8.60 million09/03/2025$1.83$1.82-0.55%$1.90$1.7942,207 shs$9.26 million09/02/2025$1.82$1.83+0.55%$1.89$1.68128,115 shs$9.31 million09/01/2025$1.82$1.82$2.05$1.8044,875 shs$9.26 million Get the Latest News and Ratings for MTNB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Matinas Biopharma and its competitors with MarketBeat's FREE daily newsletter. 08/29/2025$2.04$1.82-10.78%$2.05$1.8044,875 shs$9.26 million08/28/2025$1.98$2.04+3.03%$2.09$1.9836,292 shs$10.38 million08/27/2025$2.10$1.98-5.71%$2.15$1.89108,997 shs$10.07 million08/26/2025$2.15$2.10-2.33%$2.24$2.0278,076 shs$10.68 million08/25/2025$2.13$2.15+0.94%$2.18$1.93122,723 shs$10.94 million08/22/2025$1.74$2.13+22.41%$2.18$1.75358,565 shs$10.84 million08/21/2025$1.74$1.74$1.77$1.6678,814 shs$8.85 million08/20/2025$1.70$1.74+2.35%$1.90$1.68278,280 shs$8.85 million08/19/2025$1.71$1.70-0.58%$1.87$1.63661,059 shs$8.65 million08/18/2025$2.36$1.71-27.54%$1.95$1.332.16 million shs$8.70 million08/15/2025$1.65$2.36+43.03%$3.09$1.5922.54 million shs$12.01 million08/14/2025$1.56$1.65+6.11%$1.67$1.35111,670 shs$8.39 million Related Companies RLMD Stock Price Chart OKUR Stock Price Chart MDCX Stock Price Chart MRSN Stock Price Chart XLO Stock Price Chart MURA Stock Price Chart RNXT Stock Price Chart RANI Stock Price Chart HYPD Stock Price Chart JATT Stock Price Chart Receive MTNB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Matinas Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:MTNB) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Matinas Biopharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Matinas Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
